Evaluation of Tubercular Cervical Lymphadenopathy: Diagnostic and Therapeutic Utility

Authors

  • AKM Asaduzzaman Classified ENT Specialist & Head-Neck surgeon, Dept. of ENT and Head - Neck surgery, Combined Military Hospital, Dhaka
  • Md Kabir Uddin Classified Medicine specialist, Dept. of Medicine, Combined Military Hospital, Dhaka
  • Mohammmad Ali Azad Classified ENT Specialist& Head-Neck surgeon, Dept. of ENT and Head-Neck surgery, Combined Military Hospital, Dhaka
  • Abdullahis Safi Graded ENT Specialist & Head-Neck surgeon, Dept. of ENT and Head - Neck Surgery, Combined military hospital, Dhaka
  • Wasim Selimul Haque Classified Specialist in pathology, Dept. of Pathology, Armed Forces Institute of Pathology, Dhaka

DOI:

https://doi.org/10.3329/bjo.v23i2.45140

Keywords:

Tubercular lymphadenopathy, Anti tubercular drug, surgical treatment

Abstract

Introduction: Lymphadenitis is the most common extrapulmonary manifestation of tuberculosis. It remains both diagnostic and therapeutic challenge as not only mimics other diseases but also inconsistent physical and laboratory findings. Diagnosis is difficult often requiring biopsy.

Aim: Aim of the study was to evaluate the role of surgical dissection of tuberculous cervicle lymphadenopathy for diagnosis as well as therapeutic purpose.

Methods: This observational study was conducted during the time period of 01 july 2015 to 30 june 2017 in ENT & Pulmonology department, combined military hospital Dhaka on 100 patients who have undergone surgical neck dissection.

Result: In our study total 100 patients were biopsied. Among them 56 patient was diagnosed as tubercular lymphadenitis after lymphnode excision biopsy. Among them 47 tubercular lymphadenitis patient responded to ATT (CAT-1), only 2 patient developed cold abscess which required further surgery. Six patient showed relapse during follow-up and 9 patient did not respond to CAT-1 treatment (treatment failure). Surgical intervention along with CAT-2 treatment showed cure in all of them. 2nd surgical interventions were done in total 17 patients, 2 TB abscess during ATT (CAT-1 HRZE), 9 treatment failure patients and 6 relapse patients along with ATT (CAT-2 SHRZE) and all these patients had no relapse or treatment failure during further follow up.

Bangladesh J Otorhinolaryngol; October 2017; 23(2): 127-132

Downloads

Download data is not yet available.
Abstract
3
PDF
4

Downloads

Published

2020-01-26

How to Cite

Asaduzzaman, A., Uddin, M. K., Azad, M. A., Safi, A., & Haque, W. S. (2020). Evaluation of Tubercular Cervical Lymphadenopathy: Diagnostic and Therapeutic Utility. Bangladesh Journal of Otorhinolaryngology, 23(2), 127–132. https://doi.org/10.3329/bjo.v23i2.45140

Issue

Section

Original Articles